Arkema's Stock Rises 2.96% Despite a 14% Decline in Q1 EBITDA
The specialty chemicals company's stock soared in early trading on Wednesday, May 6, following the CAC 40, which was up 1.43%. The movement coincides with the release of the first quarter 2026 results. The financial calendar also schedules the general meeting on May 21.
The Stock Challenges the Resistance at €65.45 at Opening
Arkema gained 2.96% to €64.45, up from €62.60 at the previous close. The price approached its identified resistance at €65.45, after having risen nearly 11% over three months. The stock is now trading above the upper Bollinger Band limit set at €63.64, a configuration that indicates an acceleration of the bullish trend in recent sessions. The RSI at 61 remains in the neutral zone, without a marked overheating signal. The 50-day moving average, at €58.34, supports the medium-term dynamics. Today's progress follows the same technical sequence as the resistance breach observed in early April, when the stock had validated a threshold break at €62.10.
Q1 Marked by EBITDA Decline, Guidance Confirmed
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The company released its first quarter 2026 accounts this Wednesday. The EBITDA fell by 14% to €283 million, affected by an unfavorable exchange rate effect of approximately €20 million and the weakness of the Advanced Materials division. Despite this decline, management confirmed its target of slight EBITDA growth at constant exchange rates for the entirety of 2026. Among the risks mentioned during the Q1 release is the potential impact of the Middle East crisis on global demand and input costs. The sector context remains marked by Brent crude at around $108 per barrel, which weighs on the cost trajectory in the chemical industry. The next calendar appointment: the general meeting on May 21, followed by the publication of the half-year results on July 30.
Après des mois de janvier et février relativement faibles, la performance du premier trimestre a finalement été légèrement supérieure aux attentes.
Les volumes du Groupe sont stables, et la demande dans les segments clés est en hausse.
Risks mentioned
Impact potentiel de la crise au Moyen-Orient sur la demande mondiale.
Inflation des coûts des intrants résultant de la crise au Moyen-Orient.
Opportunities identified
Développement dans des marchés clés attractifs tels que les batteries et l'impression 3D.
Poursuite des efforts pour gérer strictement les coûts fixes.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
